TrialSafety and Efficacy of VDPHL01 in Males With AGA
Trial details
- Registry ID
- NCT06972264
- Phase
- Phase 3
Drug research
VDPHL01
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of VDPHL01 in Males With AGANCT06972264 | MANE | Phase 3 | Active not recruiting | 2026-12Estimated |
| Efficacy and Safety of VDPHL01 in Males With AGANCT06724614 | MANE | Phase 2, Phase 3 | Active not recruiting | 2026-02Estimated |
| Safety and Efficacy of VDPHL01 in Males and Females With AGANCT06527365 | MANE | Phase 2 | Active not recruiting | 2026-08Estimated |
Efficacy and Safety of VDPHL01 in Males With AGA
Trial details
- Registry ID
- NCT06724614
- Phase
- Phase 2, Phase 3
Safety and Efficacy of VDPHL01 in Males and Females With AGA
Trial details
- Registry ID
- NCT06527365
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |